Literature DB >> 2411292

Fucosylation of serum alpha-fetoprotein in patients with primary hepatocellular carcinoma.

Y Aoyagi, M Isemura, Z Yosizawa, Y Suzuki, C Sekine, T Ono, F Ichida.   

Abstract

alpha-Fetoprotein specimens were prepared from the sera of four patients with hepatocellular carcinoma. The lentil lectin-reactive and lectin-nonreactive variants of this glycoprotein were also prepared from the serum of one of the four patients by affinity chromatography with immobilized lectin. The correlation between the carbohydrate structure of these compounds and their reactivity in crossed immuno-affinoelectrophoresis with lentil lectin was studied by chemical analysis and affinity chromatography of the glycopeptides with lectin columns. It was found that the lentil lectin-reactive variant contained a carbohydrate chain of the fucosylated biantennary complex type. These data together with previous findings indicate that most of the patients with hepatocellular carcinoma have an elevated serum concentration of fucosylated alpha-fetoprotein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411292     DOI: 10.1016/0167-4838(85)90277-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

Review 1.  Occurrence and specificities of alpha 3-fucosyltransferases.

Authors:  T de Vries; D H van den Eijnden
Journal:  Histochem J       Date:  1992-11

2.  Usefulness of ED036 kit for measuring serum PIVKA-II levels in small hepatocellular carcinoma.

Authors:  R Kuromatsu; M Tanaka; Y Shimauchi; M Shimada; K Tanikawa; K Watanabe; T Yokoo
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

3.  Alpha-fetoprotein-producing carcinoma of the gallbladder.

Authors:  M Watanabe; Y Hori; T Nojima; H Kato; K Taketa; S Isogawa; K Yokoyama; S Nakagawa
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

Review 4.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

Review 5.  Glycosylation: a hallmark of cancer?

Authors:  Bhairavi N Vajaria; Prabhudas S Patel
Journal:  Glycoconj J       Date:  2016-12-14       Impact factor: 2.916

6.  Mechanisms of alpha-fetoprotein synthesis in hepatoma cells. Combined electron microscopic immunocytochemistry and autoradiography.

Authors:  M Iwai; M Kashiwadani; T Takino; Y Ibata
Journal:  Histochemistry       Date:  1989

7.  Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.

Authors:  Ryosuke Tateishi; Haruhiko Yoshida; Yutaka Matsuyama; Norio Mine; Yuji Kondo; Masao Omata
Journal:  Hepatol Int       Date:  2007-12-29       Impact factor: 6.047

8.  Alterations of glycan branching and differential expression of sialic acid on alpha fetoprotein among hepatitis patients.

Authors:  Gautam Mondal; Urmimala Chatterjee; Yogesh K Chawla; Bishnu Pada Chatterjee
Journal:  Glycoconj J       Date:  2010-12-14       Impact factor: 2.916

9.  Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma.

Authors:  Satoru Hagiwara; Masatoshi Kudo; Toshihiko Kawasaki; Miki Nagashima; Yasunori Minami; Hobyung Chung; Toyokazu Fukunaga; Masayuki Kitano; Tatsuya Nakatani
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

10.  Improvement of core-fucosylated glycoproteome coverage via alternating HCD and ETD fragmentation.

Authors:  Cheng Ma; Jingyao Qu; Xu Li; Xinyuan Zhao; Lei Li; Cong Xiao; Garrett Edmunds; Ebtesam Gashash; Jing Song; Peng George Wang
Journal:  J Proteomics       Date:  2016-06-06       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.